Carcinotech receives funding from Santander

group of people

Carcinotech founder Ishani Malhotra recieves funding from Santander as part of a summer start-up accelerator hosted and organised by Launch.ed and Edinburgh Innovations from June to August 2018. 

Related Posts

About Us

Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells.

Let’s Socialize

Popular Post